Skip to content

Shila Neupane, MD

NPI 1659002137ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Shreveport, LA

Internal Medicine, Endocrinology, Diabetes & Metabolism (MD) in Shreveport, Louisiana, licensed in LA, with an NPI issued in June 2022. Part D covered 333 prescriptions written in 2024, 78% of them generic. Insulet Corporation was the largest of 2 companies reporting payments in 2025, $147.49 in all, mostly food and beverage.

Overview

NPI1659002137
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorYes
NPI issuedJun 23, 2022
Last updated in NPPESOct 28, 2025
Certified by providerOct 28, 2025

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)333 · 552 30-day fills
Patients81
Total drug cost$46,053
Generic share78% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$147.49 · 2 payments from 2 companies

Top paying companies in 2025

CompanyAmountPayments
Insulet Corporation$132.091
Xeris Pharmaceuticals, Inc.$15.401

What the 2025 payments were for

  • Food and Beverage$147.49 · 2 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other endocrinologists in Shreveport

All 15 endocrinologists in Shreveport · All endocrinologists in Louisiana